Industry News
Pharmaceutical Industry News
Generic versions of CSL’s iron…
Generic versions of CSL’s iron replacement therapy Venofer have arrived in the U.S. after Viatris had initially touted a potential launch in 2022.
The National Advertising Division…
The National Advertising Division has sided with Genomic Health in a challenge the Exact Sciences subsidiary brought against fellow cancer diagnostics maker Agendia.
As parent company Maravai rolls…
As parent company Maravai rolls out a $50 million cost-savings drive, 90 staffers from its CDMO subsidiary TriLink are also set to lose their jobs, according to a recent layoff notice filed with the state
Discover how Fedegari’s FOB5 is…
Discover how Fedegari’s FOB5 is redefining sterilization with compact design, GMP compliance & high-containment capabilities.
Vor Bio’s big bet on RemeGen’s…
Vor Bio’s big bet on RemeGen’s autoimmune asset telitacicept appears well placed after the drug—already approved across three conditions overseas—delivered a late-stage win in a Sjögren's syndrome trial in China.
Merck has begun the 8% reduction…
Merck has begun the 8% reduction of its workforce—an initiative that the company revealed two weeks ago—with the dismissal of 58 employees at its headquarters in Rahway, New Jersey.
VML Health has stepped up its work…
VML Health has stepped up its work on advanced technology, data and AI-enabled strategies by naming Jason Reese global chief transformation officer.
Texas Attorney General Ken Paxton…
Texas Attorney General Ken Paxton and Health Choice Alliance are accusing Eli Lilly of “incentivizing” providers in the state to prescribe its drugs, including the popular diabetes and obesity medications Mounjaro and Zepbound.
As pharmas play up their U.S….
As pharmas play up their U.S. investment plans during the second Trump administration, the particulars of one project at AbbVie are coming into focus.
Robin Marcus shares how Marken is…
Robin Marcus shares how Marken is expanding patient access, supporting trial sites and driving breakthroughs in decentralized research.
With the new “Operation Access…
With the new “Operation Access Now” program, BlinkRx claims drugmakers will be able to launch direct-to-patient sales of their products within 21 days.
Pfizer and Astellas’ Padcev,…
Pfizer and Astellas' Padcev, combined with Keytruda, improved the survival outcomes of muscle-invasive bladder cancer patients who are ineligible for standard cisplatin-based chemotherapy.
The lack of an earnings call…
The lack of an earnings call accompanying Summit’s second-quarter results came after Bloomberg last month reported that the company was engaged in high-stakes licensing talks for its PD-1xVEGF antibody ivonescimab.
Four years on from its original…
Four years on from its original “Bent Carrot” ad, Endo has returned to the campaign for a new TV spot that looks at how a man overcame his concerns and sought treatment for Peyronie’s disease.
The ability to inoculate young…
The ability to inoculate young children against COVID-19 in the U.S. may be diminished this fall as the FDA weighs whether to renew the emergency green light for the vaccine currently cleared in the broadest
Sanner, a German device CDMO and…
Sanner, a German device CDMO and healthcare packaging specialist that has been on an expansion tear the last few years, named an interim chief executive to replace Dr. Johannis Willem van Vliet.
Why Young Children May Not Get Covid Shots This Fall
Under Robert F. Kennedy Jr., federal officials may withdraw an endorsement for the vaccine in younger children.
How Rick Perry Became a Fervent Advocate for the Psychedelic Ibogaine
The former Texas governor and Trump energy secretary has now dedicated his life to promoting the powerful psychedelic ibogaine.
Argenx has found a new doubles…
Argenx has found a new doubles partner for its work to raise awareness of myasthenia gravis.
The FDA on Tuesday signed off on…
The FDA on Tuesday signed off on Insmed’s brensocatib to treat non-cystic fibrosis bronchiectasis (NCFBE) in adults and kids ages 12 and up. The medicine is now available by prescription in the U.S. through a